Zacks Investment ResearchThu, 07 May 2026 18:35:36 GMTADMA Q1 EPS Jumps 73% Y/Y, Revenues Slip, 2026 View DownADMA-3.54%
Seeking AlphaThu, 07 May 2026 08:51:15 GMTADMA Biologics, Inc. (ADMA) Q1 2026 Earnings Call TranscriptADMA-3.54%
Zacks Investment ResearchTue, 05 May 2026 15:41:10 GMTWill the Label Expansion of Asceniv Boost ADMA's Top-Line Growth?ADMA-3.54%
24/7 Wall StreetMon, 04 May 2026 14:57:03 GMTAndrew Sather: Why Some Stock Buybacks Are Basically “Putting Money on Fire”ADMA-3.54%
Zacks Investment ResearchTue, 28 Apr 2026 14:31:39 GMTBrokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a BetADMA-3.54%
Zacks Investment ResearchWed, 22 Apr 2026 16:41:45 GMTWill Asceniv Deliver for ADMA in the Upcoming Quarterly Results?ADMA-3.54%
Zacks Investment ResearchThu, 16 Apr 2026 17:56:09 GMTDoes ADMA Biologics' Growth Story Outweigh Short-Seller Concerns?ADMA-3.54%
Zacks Investment ResearchWed, 15 Apr 2026 22:50:28 GMTAdma Biologics (ADMA) Exceeds Market Returns: Some Facts to ConsiderADMA-3.54%
Zacks Investment ResearchWed, 15 Apr 2026 20:01:15 GMTADMA Crashes 42.5% YTD: Right Time to Buy the Stock?ADMA-3.54%
Zacks Investment ResearchFri, 10 Apr 2026 15:00:37 GMTIs ADMA Poised for Margin Growth and Supply Expansion in 2026?ADMA-3.54%
Zacks Investment ResearchThu, 09 Apr 2026 22:50:44 GMTAdma Biologics (ADMA) Laps the Stock Market: Here's WhyADMA-3.54%
Seeking AlphaTue, 07 Apr 2026 16:23:41 GMTADMA Biologics: The Short Report Is The Noise, Not The SignalADMA-3.54%
Zacks Investment ResearchWed, 01 Apr 2026 15:26:10 GMTWill Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?ADMA-3.54%
Zacks Investment ResearchTue, 31 Mar 2026 22:46:29 GMTAdma Biologics (ADMA) Stock Declines While Market Improves: Some Information for InvestorsADMA-3.54%
Zacks Investment ResearchFri, 27 Mar 2026 16:32:12 GMTWhy Is Adma Biologics (ADMA) Down 45.4% Since Last Earnings Report?ADMA-3.54%
Zacks Investment ResearchWed, 25 Mar 2026 22:51:33 GMTAdma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You TradeADMA-3.54%
BenzingaWed, 25 Mar 2026 17:22:22 GMTShort Seller Report Alleges ADMA Biologics Financial MisrepresentationADMA-3.54%
Zacks Investment ResearchWed, 25 Mar 2026 14:35:56 GMTDown 27% in 4 Weeks, Here's Why Adma Biologics (ADMA) Looks Ripe for a TurnaroundADMA-3.54%
Zacks Investment ResearchThu, 19 Mar 2026 22:50:56 GMTAdma Biologics (ADMA) Advances While Market Declines: Some Information for InvestorsADMA-3.54%
Zacks Investment ResearchThu, 19 Mar 2026 14:30:14 GMTWall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?ADMA-3.54%
